Over the past 20 years, recombinant deoxyribonucleic acid technology h
as led to the cloning of three major thyroid specific protein genes (t
hyroglobulin, thyroperoxidase and thyrotrophin receptor), which happen
to be also the main thyroid autoantigens implicated in thyroid diseas
es. In this context, the impact that molecular genetics has had on the
understanding of aetiopathogeny and diagnosis of thyroid diseases is
summarized, with special emphasis on a recently discovered genetic mec
hanism responsible for toxic nodules. One fruitful outcome of the basi
c research on thyroid-specific gene expression has been the possibilit
y of targeting the expression of a series of genes to the thyroid in t
ransgenic mice. The result is the availability of mouse models mimicki
ng human thyroid diseases such as destructive hypothyroidism, hyperact
ive thyroid adenomas and thyroid cancers exhibiting varying levels of
differentiation.